Where does Voyager Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Voyager Therapeutics, Inc. ranks #7,961 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Voyager Therapeutics, Inc. hold?

Voyager Therapeutics, Inc. holds 41 US utility patents granted between 2019 and 2025, spanning 13 technology areas.

What is Voyager Therapeutics, Inc.'s Innovation Score?

Voyager Therapeutics, Inc. has an Innovation Score of 53.8 out of 100 (top 8% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Voyager Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Voyager Therapeutics, Inc.'s recent grant velocity is +3200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Voyager Therapeutics, Inc.'s patents?

Voyager Therapeutics, Inc.'s patents average 23.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Voyager Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Voyager Therapeutics, Inc.

Q: What technology areas does Voyager Therapeutics, Inc. focus on?

Voyager Therapeutics, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 39 patents, ranking #270 of 4,144 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 41 granted patents across 13 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Voyager ranks #7,961 of 49,997 tracked US assignees by granted-patent volume, with 41 patents across 13 technology areas.

#7,961
of 49,997 US assignees by volume: Top 8%
by Innovation Score (53.8/100): 23.6
avg claims per patent: +3200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7961 · US Corporation #7,961 · 41 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 41 grants
UPPER-Q #7,961/49,997
PHOTO-FINISH Unity Biotechnology
CPC-FOCUS C12N · 13 areas
INNOV-PAR 53.8/100
CLAIMS-DENSE 23.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +3200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Unity Biotechnology, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Voyager’s 53.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.9 pts (24%) Velocity 13.9 pts (26%) Breadth 12.7 pts (24%) Claim depth 14.2 pts (26%)

Qualcomm Incorporated · highest

85
IMS Gear SE & Kgaa · near

54
Jiangsu Academy of… · near

54
SimpliSafe · near

54
Spraying Systems · near

54
Voyager Therapeutics · this assignee

54
3D Lighting… · lowest

7

What this shows Voyager's Innovation Score is 53.8/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Voyager?

Each dot is one of Voyager’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Voyager’s own 23.6 claims/patent is ABOVE the 13.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Voyager vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Voyager's grants concentrate

Voyager Therapeutics, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 95.1% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2024 (12 grants) versus a trough of 1 in 2019. By volume, Voyager sits between Universiteit Leiden and WESTFÄLISCHE WILHELMS-UNIVERSITÄT MÜNSTER.

Voyager's three-year grant acceleration

Voyager Therapeutics, Inc. shows 23 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Universiteit Leid…

41
UniversitÉ Joseph…

41
Unity Biotechnolo…

41
University of Sha…

41
Versa Networks

41
Vitaworks IP

41
Volvo Group Canada

41
WestfÄLische Wilh…

41
Voyager Therapeut… ◀

41

What this shows Voyager holds 41 patents at rank #7,958, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Voyager

By rank, the assignees closest to #7,958 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Voyager's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Voyager, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Voyager ranks #270 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (54 here).

IMS Gear SE & Co. Kgaa 54 Spraying Systems Co. 54 Jiangsu Academy of Agricultural Sciences 54 SimpliSafe, Inc. 54

Voyager's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Voyager Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	2.4%
2020	4	9.8%
2021	6	14.6%
2022	6	14.6%
2023	5	12.2%
2024	12	29.3%
2025partial year	7	17.1%

Which technologies does Voyager Therapeutics, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 39

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 24

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 24

C07K - Peptides 17

C12Y - Enzymes 16

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 4

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

A61B - DIAGNOSIS; SURGERY; Identification 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Voyager Therapeutics, Inc.'s patent record in context - here's where to go next.

Voyager Therapeutics, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 95.1% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #7,961 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Voyager Therapeutics, Inc. against Universiteit Leiden, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.